
Deep Dive: How Eli Lilly Became the First $1 Trillion Healthcare Company
The Rundown
00:00
Is there more upside for Lilly?
Zaid introduces the bullish case: large TAM, rising adoption, international expansion, and potential oral pills.
Play episode from 05:55
Transcript


